MONDAY, DECEMBER 17, 2018
Episode #81 of 545
Fitbit Medical Director Dr. John Moore on Wearable Tech Company's New Personalized Health and Fitness Coaching Platform
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. John Moore, Medical Director of Fitbit, on their newly launched Fitbit Care - a digitally supported personal health and fitness coaching platform that provides personalized support 24/7. Dr. Moore talks about the platform's ability to help participants set achievable goals, linking their real time data to health coaches through their digital technology.
MONDAY, DECEMBER 10, 2018
Episode #82 of 545
National Cancer Institute Director Dr. Norman Sharpless on the Future of Genomics, Prevention, and Personalized Oncology
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Norman Sharpless, Director of the National Cancer Institute at the National Institutes of Health. They discuss the accelerated pace of discovery in cancer research driven by genomics, big data analytics and personalized oncology. He also stresses the need to address fragmented pockets of research for more rapid deployment of treatment breakthroughs.
MONDAY, DECEMBER 3, 2018
Episode #83 of 545
Microsoft's Voice and AI Evangelist Noelle LaCharite Talks About Transforming Healthcare With Applied AI Coding
This week, hosts Mark Masselli and Margaret Flinter speak with Noelle LaCharite Principal Program Manager for Applied AI and Cognitive Services at Microsoft, and one of the original voice 'skills' developers for Amazon's Alexa. She talks about the promise of applied AI, machine learning and voice technology systems which enable coders, developers or anyone to create their own applications and voice skills to enhance and advance the health care experience.
MONDAY, NOVEMBER 26, 2018
Episode #84 of 545
Researching Medical Marijuana and PTSD: Dr. Sue Sisley on the Quest to Expand Research on the Medicinal Potential of Cannabis
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Sue Sisley, internist, psychiatrist and President of the Scottsdale Research Institute which is conducting the nation's only FDA-approved study on the efficacy of whole plant marijuana for treatment of PTSD. She discusses her ten-year quest to complete a randomized control trial on the use of cannabis as a potentially effective approach, and restrictions that pose a challenge to expansive scientific research.
MONDAY, NOVEMBER 19, 2018
Episode #85 of 545
National Access to Primary Care and Minister of Loneliness: Dr. Charles Alessi on the UK's Approach to Population Health and Dementia Prevention
This week hosts Mark Masselli and Margaret Flinter speak with Dr. Charles Alessi, Senior Advisor for Dementia Prevention at Public Health England, the UK's equivalent of the CDC. Dr. Alessi talks about the prevention strategies being deployed across the UK to delay the onset of dementia, the lack of barriers to primary care services, and their recently announced Minister of Loneliness to confront this chronic health issue.
MONDAY, NOVEMBER 12, 2018
Episode #86 of 545
Dr. Leana Wen, Day One: Charting Planned Parenthood's Course for Protecting Women's Health
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Leana Wen, newly appointed President of the Planned Parenthood Federation of American. Dr. Wen talks about successful interventions she launched as Baltimore's Health Commissioner on opioids, maternal mortality and gun violence, planning to take her tough public health approach to addressing challenges to women's health and reproductive rights in America.
MONDAY, NOVEMBER 5, 2018
Episode #87 of 545
Targeted Therapies and Big Cost Savings: Personalized Medicine Coalition President Edward Abrahams on Precision Medicine's Potential
This week, hosts Mark Masselli and Margaret Flinter speak with Edward Abrahams, President of the Personalized Medicine Coalition which supports the emerging science of precision medicine and the huge potential it holds for cost savings with pharmacogenomics, targeted therapies, and improved outcomes for patients and health systems. They discuss the Coalition's upcoming summit at Harvard which will bring together policy makers, leading scientists, advocates and provider organizations to devise strategies for advancing precision medicine.
MONDAY, OCTOBER 29, 2018
Episode #88 of 545
"She Has Her Mother's Laugh" - New York Times Science Writer Carl Zimmer on Heredity and the Genomics Revolution
This week, hosts Mark Masselli and Margaret Flinter speak with award-winning New York Times science writer and columnist Carl Zimmer on his critically acclaimed book, "She Has Her Mother's Laugh: The Powers, Perversions and Potentials of Heredity" on the dramatic scientific discovery underway fueled by genomics. He discusses the genome's role in understanding heredity and how personalized medicine will be advanced once the science and medical communities master their knowledge of how genomics impact health and disease.
MONDAY, OCTOBER 22, 2018
Episode #89 of 545
Mental Health Crisis in America: National Council for Behavioral Health CEO Linda Rosenberg on Causes and Solutions
This week hosts Mark Masselli and Margaret Flinter speak with Linda Rosenberg, CEO of the National Council for Behavioral Health on their recent report done with the Cohen Veterans Network confirming that America's mental health crisis is a result of lack of access to care. She discusses the need to remove barriers to behavioral care, the need to embed behavioral health in primary care and for much better mental health and addiction training for providers and social workers.
MONDAY, OCTOBER 15, 2018
Episode #90 of 545
Climate Report's Dire Warnings: World Health Organization's Dr. Maria Neira on Impact of Pollution and Climate Change on Health
This week, hosts Mark Masselli and Margaret Flinter revisit their conversation with Dr. Maria Neira, Director of Public Health and the Environment at the World Health Organization who addresses the rising threat to human health from climate change and pollution - now the 4th leading cause of death worldwide. She discusses global strategies that are required to reduce the harm being done to populations around the world, especially those most vulnerable, in the wake of advancing climate change and unmitigated pollution.
MONDAY, OCTOBER 8, 2018
Episode #91 of 545
The Political Challenges in American Health Reform: Former CMS Administrator Don Berwick on the Need for Clinician Activism
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Don Berwick, President Emeritus of the Institute for Healthcare Improvement and former CMS Administrator who oversaw the launch of the Affordable Care Act. He talks about inherent political challenges in American health care, the need for providers to get active politically, and the promise of real innovations in the health system coming from outside the industry.
MONDAY, OCTOBER 1, 2018
Episode #92 of 545
America's Addiction Crisis: Treatment Research Institute Founder Dr. Tom McLellan on Science-Based Approach to Drug Treatment and Policy
This week, hosts Mark Masselli and Margaret Flinter speak with renowned addiction expert Dr. Tom McLellan, Founder and CEO of the Treatment Research Institute, committed to promoting evidence-based approaches to drug treatment and drug policy. He discusses addiction as a chronic disorder, the effectiveness of Medication Assisted Treatment (MAT) for opioid and alcohol addiction, and the need to improve addiction medicine training for clinicians and health care providers.
MONDAY, SEPTEMBER 24, 2018
Episode #93 of 545
Apple Watch, Fitbit, AI and Alexa: Yahoo Tech Founder David Pogue on Game-Changing Potential in Health Care
This week, hosts Mark Masselli and Margaret Flinter speak with David Pogue, long-time personal tech critic and founder of Yahoo Tech. He discusses the great promise in the growth of consumer technology innovations - Apple Watch, Fitbit and voice recognition platforms like Alexa - to transform health care by informing and empowering consumers and providers.
MONDAY, SEPTEMBER 17, 2018
Episode #94 of 545
Disrupting the Generic Drug Market: Gary and Mary West Foundation CEO Shelley Lyford on Civica Rx Launch
This week, hosts Mark Masselli and Margaret Flinter speak with Shelley Lyford, CEO of the Gary and Mary West Foundation which is dedicated to reducing costs and improving care for America's seniors. She discusses the launch of Civica Rx - a not for profit entity that will supply low-cost generic drugs to a consortium of partner foundations and hospitals to disrupt monopolies and price gouging in the pharmaceutical industry.
MONDAY, SEPTEMBER 10, 2018
Episode #95 of 545
Transforming Care Delivery for Underserved Populations: Cityblock CEO Iyah Romm on Their Tech-Based Solutions
This week, hosts Mark Masselli and Margaret Flinter speak with Iyah Romm, CEO of Cityblock Health, a venture with Alphabet's Sidewalk Labs aimed at improving care and outcomes for underserved populations in urban areas by deploying tech-based solutions supporting patients and care teams. He talks about Cityblock's development of digital and telehealth tools that enable real time monitoring of patient data, and a network of interventions addressing social determinants of health.
MONDAY, SEPTEMBER 3, 2018
Episode #96 of 545
Walgreens' RX for Fixing Health Care: Chief Medical Officer Dr. Patrick Carroll on Health Services Growth in Pharmacy Setting
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Patrick Carroll, Chief Medical Officer at Walgreens Healthcare where he oversees the pharmacy chain's expanded primary care and prevention health services in nearly 10 thousand retail pharmacies. They discuss Walgreens' expansion of digital and telehealth interventions for behavioral health, medication compliance and chronic illness management, with expanded health services being offered in the pharmacy clinics.
MONDAY, AUGUST 27, 2018
Episode #97 of 545
Telehealth, Best Practices and Integrated Care: Dr. Charles Sorenson on Intermountain Healthcare's Commitment to Innovation
This week, hosts Mark Masselli and Margaret Flinter speak with Intermountain Healthcare of Utah's CEO Emeritus Dr. Charles Sorenson, who discusses Intermountain's innovative, integrated care delivery system committed to improved outcomes and contained costs. He is Founding Director of the Intermountain Healthcare Leadership Institute which seeks to train future clinician leaders in their team-based model of care delivery.
MONDAY, AUGUST 20, 2018
Episode #98 of 545
Alexa and Telemedicine in Health Care: Harvard's Dr. John Halamka on Promising Health Tech Trends to Watch
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. John Halamka, Chief Information Officer for Harvard Medical School and Beth Israel Deaconess Medical Center in Boston where he has launched a new endeavor: the Health Technology Exploration Center. The lab is an incubator for studying emerging technologies in health care such as telemedicine, genomics, blockchain, wearables and smart speakers like Alexa that could potentially improve clinical workflow, data sharing and outcomes.
MONDAY, AUGUST 13, 2018
Episode #99 of 545
Millions Served: NACHC's Dan Hawkins on Community Health Centers Delivering Care to Vulnerable Americans
This week, hosts Mark Masselli and Margaret Flinter speak with Dan Hawkins, Sr. VP for Public Policy and Research at the National Association of Community Health Centers (NACHC), which supports the thousands of chc's providing care for 27 million underserved Americans. They discuss the care model that embeds behavioral and dental care within primary care, the growing reliance on Nurse Practitioners as front line clinicians, and the training, innovation and quality care the nation's health centers provide.
MONDAY, AUGUST 6, 2018
Episode #100 of 545
CRISPR, DNA and Genomics: Dr. Samuel Sternberg Examines This Game-Changing Technology
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Samuel H. Sternberg, assistant professor in the Department of Biochemistry and Molecular Biophysics at Columbia University and renowned expert on CRISPER-Cas9 gene editing technology. Dr. Sternberg co-authored "A Crack in Creation" with CRISPR co-creator Jennifer Doudna, and talks about the limitless potential of this genetic engineering tool to transform how we treat and prevent disease in the future.